Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions

Neurology

Volumn 76, Issue 6, 2011, Pages 534-539

  Tallantyre, E C ^a   Dixon, J E ^a   Donaldson, I ^a   Owens, T ^b   Morgan, P S ^b,c   Morris, P G ^a   Evangelou, N ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ADULT; AGED; ARTICLE; BRAIN DAMAGE; BRAIN VENTRICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SUBCORTEX; WHITE MATTER BRAIN LESION;

ADULT; AGED; ASYMPTOMATIC DISEASES; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED; YOUNG ADULT;

EID: 79951609886     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31820b7630     Document Type: Article

References (16)

1. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neurol 2005;58:840-846. (Pubitemid 41746873)
2. Newcombe J, Hawkins CP, Henderson CL, et al. Histo-pathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue. Brain 1991;114:1013-1023.
3. Ormerod IE, Miller DH, McDonald WI, et al. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions: a quantitative study. Brain 1987;110:1579-1616.
4. Liao D, Cooper L, Cai J, et al. The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. Neuroepidemiology 1997;16: 149-162. (Pubitemid 27215864)
5. Shintani S, Shiigai T, Arinami T. Silent lacunar infarction on magnetic resonance imaging (MRI): risk factors. J Neurol Sci 1998;160:82-86. (Pubitemid 28473890)
6. Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperin-tensities. Neurology 1993;43:1683-1689. (Pubitemid 23307935)
7. Tallantyre EC, Brookes MJ, Dixon JE, Morgan PS, Evan-gelou N, Morris PG. Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI. Neurology 2008;70:2076-2078.
8. Morgan PS. Image analysis and related computer issues. Available at: http://www.nottingham.ac.uk/~njzwww/paul/software. Accessed August 5, 2009.
9. Rorden C, Brett M. Stereotaxic display of brain lesions. Behav Neurol 2000;12:191-200. (Pubitemid 32843166)
10. Fazekas F, Offenbacher H, Fuchs S, et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology 1988; 38:1822-1825. (Pubitemid 19004571)
11. Coles AJ, Compston DA, Selmaj KW, et al. Alemtuzumab vs interferon beta-1a in early multiple sclerosis. N Engl J Med 2008;359:1786-1801.
12. Offenbacher H, Fazekas F, Schmidt R, et al. Assessment of MRI criteria for a diagnosis of MS. Neurology 1993;43: 905-909. (Pubitemid 23150560)
13. Miller DH, McDonald WI, Smith KJ. The diagnosis of multiple sclerosis. In: Compston A, ed. McAlpine's Multiple Sclerosis. London: Churchill Livingstone Elsevier; 2005: 372.
14. Tallantyre EC, Morgan PS, Dixon JE, et al. A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions. Invest Radiol 2009;44:491-494.
15. Dixon JE, Tallantyre EC, Morgan PS, Evangelou N, Morris PG. Optimisation of 3 T and 7 T T2*-weighted MRI for the detection of small parenchymal veins in MS lesions. Int Soc Magn Reson Med 2010;18:4322.
16. Lummel N, Boeckh-Behrens T, Schoepf V, Burke M, Bruckmann H, Linn J. Presence of a central vein within white matter lesions on susceptibility weighted imaging: a specific finding for multiple sclerosis? Neuroradiology Epub 2010 Jun 29.